id:"swepub:oai:DiVA.org:kth-330105"
Search: id:"swepub:oai:DiVA.org:kth-330105" > Breast cancer patie...
- 1 of 1
- Previous record
- Next record
- To hitlist
Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction
-
- Chen, Xinsong (author)
- Karolinska Institutet
-
- Sifakis, Emmanouil G. (author)
- Karolinska Institutet
-
- Robertson, Stephanie (author)
- Karolinska Institutet
- show more...
- show less...
- (creator_code:org_t)
- 2022-12-27
- 2023
- English.
- In: Proceedings of the National Academy of Sciences of the United States of America. - : Proceedings of the National Academy of Sciences. - 0027-8424 .- 1091-6490. ; 120:1
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Breast cancer (BC) is a complex disease comprising multiple distinct subtypes with different genetic features and pathological characteristics. Although a large number of antineoplastic compounds have been approved for clinical use, patient-to-patient variability in drug response is frequently observed, highlighting the need for efficient treatment prediction for individualized therapy. Several patient-derived models have been established lately for the prediction of drug response. However, each of these models has its limitations that impede their clinical application. Here, we report that the whole-tumor cell culture (WTC) ex vivo model could be stably established from all breast tumors with a high success rate (98 out of 116), and it could reassemble the parental tumors with the endogenous microenvironment. We observed strong clinical associations and predictive values from the investigation of a broad range of BC therapies with WTCs derived from a patient cohort. The accuracy was further supported by the correlation between WTC-based test results and patients' clinical responses in a separate validation study, where the neoadjuvant treatment regimens of 15 BC patients were mimicked. Collectively, the WTC model allows us to accomplish personalized drug testing within 10 d, even for small-sized tumors, highlighting its potential for individualized BC therapy. Furthermore, coupled with genomic and transcriptomic analyses, WTC-based testing can also help to stratify specific patient groups for assignment into appropriate clinical trials, as well as validate potential biomarkers during drug development.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Keyword
- breast cancer
- drug profiling
- ex vivo culture
- precision oncology
- whole-tumor cell culture
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Proceedings of the National Academy of Sciences of the United States of America (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Chen, Xinsong
- Sifakis, Emmanou ...
- Robertson, Steph ...
- Neo, Shi Yong
- Jun, Seong-Hwan
- Tong, Le
- show more...
- Min, Apple Tay H ...
- Lövrot, John
- Hellgren, Roxann ...
- Margolin, Sara
- Bergh, Jonas
- Foukakis, Theodo ...
- Lagergren, Jens
- Lundqvist, Andre ...
- Ma, Ran
- Hartman, Johan
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Cancer and Oncol ...
- Articles in the publication
- Proceedings of t ...
- By the university
- Royal Institute of Technology
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
